Disclosing the benefits of multi-strain compounds and their health impact mechanisms utilizing intestinal biomimetic technology.

Front Microbiol

State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, China.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The gut microbiota plays a vital function in preserving intestinal homeostasis and general health. This study examined the impacts of a composite probiotic based on an fermentation system and an organoid interaction research platform to investigate the effects of composite probiotics. 4P, investigating the impact of gut barrier function through the utilization of and organoid models. Our findings revealed that 4P demonstrated excellent capabilities for producing short-chain fatty acids, modulating intestinal gas metabolism, and regulating oxidative-reduction potential. Furthermore, the individual strains that comprise 4P were selected for subsequent organoid studies based on previous strain culture experiments. Our results suggest that 4P and its individual strains hold promise for preserving the gut barrier integrity and function, thereby potentially offering therapeutic benefits in the context of intestinal disorders. These findings underscore the importance of exploring the mechanistic actions of composite probiotics in maintaining gut health and preventing diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12119514PMC
http://dx.doi.org/10.3389/fmicb.2025.1550913DOI Listing

Publication Analysis

Top Keywords

composite probiotics
8
gut barrier
8
individual strains
8
disclosing benefits
4
benefits multi-strain
4
multi-strain compounds
4
compounds health
4
health impact
4
impact mechanisms
4
mechanisms utilizing
4

Similar Publications

Can We Combine Mouthrinses With Probiotics? An Evaluation of Their Compatibility and Combined Therapy on Oral Biofilms.

J Periodontal Res

September 2025

Department of Oral Health Sciences, Periodontology and Oral Microbiology, KU Leuven, Leuven, Belgium.

Aim: Multiple oral pathologies requiring antiseptic mouthrinses for prevention or treatment. However, nonselective elimination of the microbes may also harm beneficial commensal, healthy bacteria. Promicrobial strategies, such as probiotics, aim to rebalance the oral microbiome rather than eradicate it; however, we hypothesised that their incorporation might be challenged due to the microbiome's inherent resistance to outsiders.

View Article and Find Full Text PDF

Gut microbiome and rheumatoid arthritis: Revisiting the gut-joint axis.

Int Immunopharmacol

September 2025

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

Over the past few decades, the scientific perspective on gut microbiota has undergone a profound transformation, particularly with the emergence and advancement of microbiome research. Next-generation sequencing technologies have emerged as a foundational tool in microbiome research, facilitating comprehensive characterization of microbial communities across diverse sample types and ecological niches. Significant alterations in gut microbiota composition have been observed in disease states compared to healthy individuals, suggesting a direct association between gut dysbiosis and host health status.

View Article and Find Full Text PDF

Pharmacological insights into gut microbiota modulation in systemic lupus erythematosus: Mechanisms, treatment strategies, and clinical implications.

J Pharmacol Exp Ther

July 2025

Department of Pharmacy Practice, Parul Institute of Pharmacy & Research, Parul University, Limda, Waghodia, Vadodara, Gujarat, India. Electronic address:

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by widespread inflammation and immune system dysregulation. Recent research suggests that the gut microbiota may play a role in the development of SLE by modulating immune system responses, affecting cytokine production, and altering the activity of T and B cells lymphocytes. As a result, there is a growing interest in microbiota-targeted therapies, including probiotics, dietary changes, and fecal microbiota transplantation.

View Article and Find Full Text PDF

Effects and Mechanisms of Lactiplantibacillus plantarum G83 on Enterotoxigenic Escherichia coli (ETEC)-Induced Intestinal Inflammation.

Probiotics Antimicrob Proteins

September 2025

Key Laboratory of the Ministry of Education for Wildlife and Plant Resources Conservation in Southwest China, College of Life Sciences, China West Normal University, Nanchong, Sichuan, China.

Enterotoxigenic Escherichia coli (ETEC) is a prevalent intestinal pathogen that significantly impacts both human and animal health. G83, isolated from giant panda feces, has demonstrated notable probiotic properties. In this study, C57BL/6 J mice were randomly divided into Control, ETEC, and G83 groups.

View Article and Find Full Text PDF

Currently, there is an increasing use of whole-genome sequencing (WGS) studies to investigate the molecular taxonomy, metabolic properties, enzyme capabilities, and bioactive substances of lactic acid bacteria (LAB) species. In this study, the genome of strain Pediococcus pentosaceus BBS1 was sequenced using the Illumina HiSeq. 2500 platform to determine its classification, annotate its main features, and evaluate its safety characteristics.

View Article and Find Full Text PDF